Cloudflare is breaking out just as investors are beginning to reprice the company as more than a cybersecurity platform.
The drugmaker is paying up for a new growth engine. Is the price disciplined?
Vertex Pharmaceuticals will acquire Crinetics Pharmaceuticals for a total equity value of about $10B, or nearly $8.8B net of estimated cash acquired, both companies said on Monday ...
This buy gives Vertex both a recently-commercialized drug, and a very strong lead candidate.
Vertex Pharmaceuticals Incorporated’s $10B Crinetics Pharmaceuticals, Inc. buy adds PALSONIFY & a Phase 3 CAH asset. Click ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results